This blog is related to the various litigations related to patents w.r.t pharma industry.
Monday, March 2, 2009
US Food and Drug Administration Issues Complete Response Letter Regarding the Tracleer Supplemental New Drug Application
02 March 2009 - Actelion Ltd announced today it has received a complete response letter from the US FDA regarding the supplemental New Drug Application the company filed in August 2007.
No comments:
Post a Comment